MonnierL, ColetteC, OwensD. Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts. Diabetes Technol Ther, 2011; 13(Suppl. 1):S25–S32; doi: 10.1089/dia.2010.0239
2.
MonnierL, LapinskiH, ColetteC. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia in type 2 diabetes. Variations with increasing levels of HbA1c. Diabetes Care, 2003; 26(3):881–885; doi: 10.2337/diacare.26.3.881
3.
MonnierL, ColetteC, DunseathG, et al.The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care, 2007; 30(2):263–269; doi: 10.2337/dc06-1612
4.
MonnierL, ColetteC, DejagerS, et al.Residual dysglycemia when at target HbA1c of 7% (53 mmol/mol) in persons with type 2 diabetes. Diabetes Res Clin Pract, 2014; 104(3):370–375; doi: 10.1016/j.diabres.2014.03.012
5.
UemuraF, OkadaY, TorimotoK, et al.Association between time in range and postprandial glucose contribution rate in non-insulin-treated type 2 diabetic patients: Inverse correlation of time in range with postprandial glucose contribution rate. Diabetes Technol Ther, 2022; doi: 10.1089/dia.2022.0194
6.
VigerskyRA, Mc MahonC. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther, 2019; 21(2):81–85; doi: 10.1089/dia.2018.0310
7.
BeckRW, BergenstalRM, ChengP, et al.The relationship between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol, 2019; 13(4):614–626; doi: 10.1177/1932296818822496
8.
DinneenS, GerichJE, RizzaR. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. New Engl J Med, 1988; 318:1231–1239; doi: 10.1056/NEJM199209033271007
9.
MonnierL. Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?. Eur J Clin Invest, 2000; 30(Suppl. 2):3–11; doi: 10.1046/j.1365-2362.30.s2.2.2x
10.
BodenG, ChenX, UrbainJL. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes, 1996; 45(8):1044–1050; doi: 10.2337/diab.45.8.1044
11.
MonnierL, ColetteC, DejagerS, et al.Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes. Diabetes Care, 2013; 36(12):4057–4062; doi: 10.2337/dc12-2127
12.
American Diabetes Association Professional Practice Committee. Glycemic targets: Standards of Medical Care in diabetes-2022. Diabetes Care, 2022; 45(Suppl. 1):S83–S96; doi: 10.2337/dc22-S006
13.
International Diabetes Federation Guidelines Development group. Guidelines for management of postmeal glucose in diabetes. Diabetes Res Clin Pract, 2014; 103:256–268; doi: 10.1016/j.diabres.2012.08.002
14.
CerielloA. Postprandial hyperglycemia and diabetes complications. Is it time to treat?. Diabetes, 2005; 54(1):1–7; doi: 10.2337/diabetes.54.1.1
